Table I.
A, Driver genes | ||||
---|---|---|---|---|
0.5% as cutoff | 5% as cutoff | |||
Gene | Positive cases | Positive rate, % | Positive cases | Positive rate, % |
KRAS | 61 | 52.1 | 50 | 42.7 |
KIT | 23 | 19.7 | 11 | 9.4 |
PIK3CA | 35 | 29.9 | 19 | 16.2 |
MET | 18 | 15.4 | 10 | 8.5 |
EGFR | 17 | 14.5 | 1 | 0.9 |
BRAF | 14 | 12 | 6 | 5.1 |
IDH1 | 14 | 12 | 1 | 0.9 |
PDGFR3 | 10 | 8.5 | 0 | 0 |
CTNNB1 | 8 | 6.8 | 5 | 4.2 |
IDH2 | 8 | 6.8 | 0 | 0 |
HER2 | 6 | 5.1 | 1 | 0.9 |
SMO | 6 | 5.1 | 1 | 0.9 |
B, Tumor suppressor genes | ||||
0.5% as cutoff | 5% as cutoff | |||
Gene | Positive cases | Positive rate, % | Positive cases | Positive rate, % |
TP53 | 77 | 65.8 | 56 | 47.9 |
APC | 46 | 39.3 | 34 | 29.1 |
CDKN2A | 38 | 32.5 | 1 | 0.9 |
STK11 | 23 | 19.7 | 11 | 9.4 |
FBXW7 | 23 | 19.7 | 8 | 6.8 |
PTEN | 19 | 16.2 | 2 | 1.7 |
SMAD4 | 14 | 12 | 3 | 2.6 |
MLH1 | 12 | 10.3 | 7 | 6 |
VHL | 10 | 8.5 | 2 | 1.7 |
ATM | 9 | 7.7 | 2 | 1.7 |
RB1 | 7 | 6 | 0 | 0 |
HNF1A | 7 | 6 | 0 | 0 |
SMARCB1 | 6 | 5.1 | 2 | 1.7 |